Company

Translate Bio, Inc.

Translate Bio developed messenger RNA therapeutics for diseases.

About

Founded in 2011 and based in Lexington, US, Translate Bio developed messenger RNA therapeutics for diseases. In 2020, the company reported revenue of USD 138.81 mn and EBITDA of USD -46.05 mn. Sanofi S.A. acquired Translate Bio in a trade sale for USD 3.2 billion.

4Funding rounds

9Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in